ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,799,341 | -22.9% | 5,694 | -38.9% | 0.36% | -20.3% |
| Q2 2023 | $3,633,063 | +31.1% | 9,322 | +25.3% | 0.45% | +19.5% |
| Q1 2023 | $2,771,995 | -7.6% | 7,440 | -6.1% | 0.38% | -16.1% |
| Q4 2022 | $3,000,334 | +4.9% | 7,920 | -2.3% | 0.45% | +3.0% |
| Q3 2022 | $2,861,000 | -7.0% | 8,104 | -0.1% | 0.43% | -3.1% |
| Q2 2022 | $3,075,000 | +13.6% | 8,115 | -5.5% | 0.45% | +48.8% |
| Q1 2022 | $2,708,000 | -42.6% | 8,588 | -36.3% | 0.30% | -24.4% |
| Q4 2021 | $4,718,000 | +14.0% | 13,473 | -1.7% | 0.40% | +9.0% |
| Q3 2021 | $4,139,000 | -1.9% | 13,707 | -2.2% | 0.36% | -1.1% |
| Q2 2021 | $4,221,000 | +1.5% | 14,019 | -7.2% | 0.37% | -4.7% |
| Q1 2021 | $4,160,000 | -8.1% | 15,104 | -1.9% | 0.39% | -3.0% |
| Q4 2020 | $4,528,000 | -11.7% | 15,398 | -21.2% | 0.40% | 0.0% |
| Q3 2020 | $5,130,000 | +9.1% | 19,542 | -6.4% | 0.40% | +1.0% |
| Q2 2020 | $4,704,000 | +10.2% | 20,884 | -35.6% | 0.40% | -9.6% |
| Q1 2020 | $4,270,000 | -29.3% | 32,413 | -13.8% | 0.44% | -1.4% |
| Q4 2019 | $6,038,000 | +35.6% | 37,621 | -3.7% | 0.44% | +32.2% |
| Q3 2019 | $4,454,000 | +100.5% | 39,082 | +149.2% | 0.34% | +117.5% |
| Q2 2019 | $2,221,000 | – | 15,684 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |